KDNY(Delisted)
Chinook TherapeuticsยทNASDAQ
--
--(--)
KDNY Profile
Chinook Therapeutics, Inc.
A clinical-stage biopharmaceutical company that developing medicines for chronic kidney diseases
400 Fairview Avenue North, Suite 900, Seattle, WA, 98109
--
Chinook Therapeutics, Inc., is a clinical-stage biotechnology company that develops precision medicines for kidney disease. The company's product candidates are investigating rare, serious chronic kidney disease opportunities with a clear clinical pathway. The Company's main project is Atlasentan, an investigational phase 3 endothelin receptor antagonist for the treatment of IgA nephropathy and other primary glomerular diseases.
